Amgen Stock Price and Value Analysis

Should you buy Amgen stock? (NasdaqGS:AMGN). Let's see how it does in our automated value investing analysis system.

  • This company has a high dividend yield.
  • This company has fluctuating growth.
  • This company is very stable.
  • This company is making money at a modest rate.
  • This stock looks overpriced.

Inside the AMGN Numbers

AMGN Price
(Amgen stock price per share)
[?] AMGN Fair Price
(based on intrinsic value)
[?] AMGN Safety Price (based on a variable margin of safety) $100.94
[?] PE Ratio versus Sector 8% higher than other Healthcare stocks
[?] PE Ratio versus Industry 7% lower than other Unknown stocks
[?] Cash Yield 7.03%
[?] Free Cash Flow Jitter 32%
[?] Dividend Yield 3%
Shares Shorted 16,835,371

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 16,835,371 shares shorted. With 533,850,290 shares available for purchase and an average trading volume over the past 10 trading days of 2,862,690, it would take at least 5.881 days for all of the short holders to cover their shorts.

Is Amgen Stock on Sale?

We believe that Amgen may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Amgen looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy AMGN Stock?

Does Amgen have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.